Biondvax Pharmaceuticals (BVXV) null Earnings

28MarConfirmed
Aug 21
Nov 21
Q4 2021
Mar 22
-2.7
-1.8
-0.9
-0.01

Details

Expected EPS
-0.85
Actual EPS
-2.7
Surprise EPS
-1.85
Surprise Percent
+217.65%

Description

Biondvax Pharmaceuticals (BVXV) has reported earnings of -2.7 per share for .

0 Comments

Share your thoughts